CASE NUMBER
2:2024bk10583
2:2024bk10583
TYPE / CHAPTER
Voluntary / 11
Voluntary / 11
Docket Entries by Month
| Feb 22 | 1 | Petition Chapter 11 Voluntary Petition for Non-individual. Fee Amount $1738 Filed by Baudax Bio, Inc.. Chapter 11 Plan due by 06/21/2024. Statement of Corporate Ownership due 03/7/2024. Corporate Resolution due 03/7/2024. Atty Disclosure Statement due 03/7/2024. Schedule A/B due 03/7/2024. Schedule D due 03/7/2024. Schedule E/F due 03/7/2024. Schedule G due 03/7/2024. Schedule H due 03/7/2024. Statement of Financial Affairs due 03/7/2024. Summary of Assets and Liabilities due 03/7/2024. Incomplete Filings due by 03/7/2024. (SMITH, DAVID) (Entered: 02/22/2024) | |
|---|---|---|---|
| Feb 22 | 2 | Matrix List of Creditors Filed. Number of pages filed: 24, Filed by DAVID B. SMITH on behalf of Baudax Bio, Inc.. (SMITH, DAVID) (Entered: 02/22/2024) | |
| Feb 22 | Receipt of Voluntary Petition (Chapter 11)( 24-10583) [misc,volp11a] (1738.00) Filing Fee. Receipt number A25543139. Fee Amount $1738.00. (re: Doc# 1) (U.S. Treasury) (Entered: 02/22/2024) | ||
| Feb 23 | 3 | ENTRY OF APPEARANCE AND REQUEST FOR NOTICES, pursuant to Federal Bankruptcy Rules 2002 and 9010, KEVIN P. CALLAHAN hereby appears in this matter on behalf of the United States trustee for Region 3, and demands that all notices, motions, etc., given or required to be given in this case, and that all papers, etc., served in this case, be given to and served upon me at the address listed on this case party list. Filed by KEVIN P. CALLAHAN on behalf of United States Trustee. (CALLAHAN, KEVIN) (Entered: 02/23/2024) | |
| Feb 23 | 4 | Corporate Resolution Filed by NICHOLAS M. ENGEL on behalf of Baudax Bio, Inc.. (ENGEL, NICHOLAS) (Entered: 02/23/2024) | |
| Feb 23 | 5 | Document in re: CERTIFICATE OF SERVICE OF NOTICE TO CREDITORS WITH AN INTEREST IN CASH COLLATERAL Filed by NICHOLAS M. ENGEL on behalf of Baudax Bio, Inc.. (ENGEL, NICHOLAS) (Entered: 02/23/2024) | |
| Feb 23 | 6 | Document in re: STATEMENT OF QUALIFICATION AS COMPLEX CHAPTER 11 CASE Filed by NICHOLAS M. ENGEL on behalf of Baudax Bio, Inc.. (ENGEL, NICHOLAS) (Entered: 02/23/2024) | |
| Feb 23 | 7 | Chapter 11 or Chapter 9 Cases Non-Individual: List of Creditors Who Have 20 Largest Unsecured Claims Against You and Are Not Insiders. Filed by NICHOLAS M. ENGEL on behalf of Baudax Bio, Inc. . (R., Donna) (Entered: 02/23/2024) | |
| Feb 23 | 8 | Statement of Corporate Ownership filed. Filed by NICHOLAS M. ENGEL on behalf of Baudax Bio, Inc. . (R., Donna) (Entered: 02/23/2024) | |
| Feb 23 | 9 | Order Entered the debtor having failed to file or submit with the petition all of the documents required by Fed. R. Bankr.P.1007, It is hereby ORDERED that this case MAY BE DISMISSED WITHOUT FURTHER NOTICE if the documents listed are not filed by deadlines listed. Any request for an extension of time must be filed prior to the expiration of the deadlines listed. Atty Disclosure Statement due 3/7/2024. List of Equity Security Holders due 3/7/2024. Schedule A/B due 3/7/2024. Schedule D due 3/7/2024. Schedule E/F due 3/7/2024. Schedule G due 3/7/2024. Schedule H due 3/7/2024. Statement of Financial Affairs due 3/7/2024. Summary of Assets and Liabilities due 3/7/2024. (R., Donna) (Entered: 02/23/2024) | |
| Feb 23 | 10 | Meeting of Creditors. 341(a) meeting to be held on 3/29/2024 at 10:00 AM at ALTERNATE TELEPHONIC CONFERENCE (For Trustee Use Only). Government Proof of Claim Deadline: 08/20/2024. (MILLER, NANCY) (Entered: 02/23/2024) | |
There are 5 newer docket entries.To see the entire docket, login, subscribe now, or purchase this single case. |
|||
| A&L Goodbody |
|---|
| ABC/Amega |
| Accenture LLP |
| Advarra, Inc. |
| Agilent Technologies, Inc. |
| Almac Sciences Ireland Ltd |
| AlphaVektor, LLC |
| Alturas Analytics, Inc. |
| American Express |
| American Express |
| American Society for Enhanced Recovery |
| American Society of Anesthesiologists |
| American Society of Colon and |
| Amy Thomas |
| Andrew Dreschler |
Baudax Bio, Inc.
490 Lapp Road
Malvern, PA 19355
CHESTER-PA
Tax ID / EIN: xx-xxx9500
NICHOLAS M. ENGEL
Smith Kane Holman, LLC
112 Moores Road
Suite 300
Malvern, PA 19355
610-407-7216
Fax : 610-407-7218
Email: nengel@skhlaw.com
DAVID B. SMITH
Smith Kane Holman, LLC
112 Moores Road, Suite 300
Malvern, PA 19355
(610) 407-7217
Fax : (610) 407-7218
Email: dsmith@skhlaw.com
United States Trustee
Office of United States Trustee
Robert N.C. Nix Federal Building
900 Market Street
Suite 320
Philadelphia, PA 19107
(215)597-4411
KEVIN P. CALLAHAN
DOJ-Ust
Robert N.C. Nix Federal Building
900 Market Street
Ste. 320
Philadelphia, PA 19107
215-597-4411
Email: kevin.p.callahan@usdoj.gov
| Date Filed | Name = parent case |
Chapter | Case # |
|---|---|---|---|
| Oct 23, 2022 | PhaseBio Pharmaceuticals, Inc. | 11 | 1:2022bk10995 |
| Aug 16, 2022 |
Actient Therapeutics LLC
|
11 | 7:2022bk22588 |
| Aug 16, 2022 |
Endo Management Limited
|
11 | 7:2022bk22587 |
| Aug 16, 2022 |
Endo Luxembourg International Financing S.a'
|
11 | 7:2022bk22585 |
| Aug 16, 2022 |
Endo Luxembourg Holding Company S.a' r.l.
|
11 | 7:2022bk22583 |
| Aug 16, 2022 |
Endo Luxembourg Finance Company I S. r.l.
|
11 | 7:2022bk22581 |
| Aug 16, 2022 |
Endo LLC
|
11 | 7:2022bk22579 |
| Aug 16, 2022 |
Endo Ireland Finance II Limited
|
11 | 7:2022bk22577 |
| Aug 16, 2022 |
Endo Innovation Valera, LLC
|
11 | 7:2022bk22575 |
| Aug 16, 2022 |
Endo Health Solutions Inc.
|
11 | 7:2022bk22573 |
| Aug 16, 2022 |
Endo Global Ventures
|
11 | 7:2022bk22571 |
| Aug 16, 2022 |
Endo Global Finance LLC
|
11 | 7:2022bk22570 |
| Aug 16, 2022 |
Endo Global Development Limited
|
11 | 7:2022bk22568 |
| Aug 16, 2022 |
Endo Global Biologics Limited
|
11 | 7:2022bk22566 |
| Aug 16, 2022 |
Endo Global Aesthetics Limited
|
11 | 7:2022bk22564 |
